Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering
Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharma Ltd. On A $8.0 M At-The-Market Registered Direct Offering
New York, NY – (Global Newswire) – 12/20/2014 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Israeli biopharmaceutical company, Can-Fite Biopharma Ltd. (TASE: CFBI; NYSE MKT: CANF) on an at-the-market registered direct offering of for gross proceeds of $8,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Associates Gary Emmanuel and Avital Even-Shoshan. H.C. Wainwright & Co., LLC acted as the Placement Agent in the offering.
- Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in Close of $3.4 Million Underwritten Public Offering of Common Stock - August 1, 2020
- Relief for Retirement Account Owners During COVID-19 - July 30, 2020
- Sichenzia Ross Ference LLP Represents Immuron Limited in $20 Million Registered Direct Offering - July 24, 2020